Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments

Bibliographic Details
Main Authors: Alejandro Ramírez-Chacón, Sergi Betriu-Méndez, Ariadna Bartoló-Ibars, Azucena González, Mercè Martí, Manel Juan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1078003/full
_version_ 1811309065987424256
author Alejandro Ramírez-Chacón
Alejandro Ramírez-Chacón
Sergi Betriu-Méndez
Sergi Betriu-Méndez
Ariadna Bartoló-Ibars
Ariadna Bartoló-Ibars
Azucena González
Azucena González
Azucena González
Mercè Martí
Mercè Martí
Manel Juan
Manel Juan
Manel Juan
author_facet Alejandro Ramírez-Chacón
Alejandro Ramírez-Chacón
Sergi Betriu-Méndez
Sergi Betriu-Méndez
Ariadna Bartoló-Ibars
Ariadna Bartoló-Ibars
Azucena González
Azucena González
Azucena González
Mercè Martí
Mercè Martí
Manel Juan
Manel Juan
Manel Juan
author_sort Alejandro Ramírez-Chacón
collection DOAJ
first_indexed 2024-04-13T09:34:41Z
format Article
id doaj.art-98ff8fd27267475b983e612e0ef9d98b
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-13T09:34:41Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-98ff8fd27267475b983e612e0ef9d98b2022-12-22T02:52:08ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-11-011310.3389/fimmu.2022.10780031078003Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatmentsAlejandro Ramírez-Chacón0Alejandro Ramírez-Chacón1Sergi Betriu-Méndez2Sergi Betriu-Méndez3Ariadna Bartoló-Ibars4Ariadna Bartoló-Ibars5Azucena González6Azucena González7Azucena González8Mercè Martí9Mercè Martí10Manel Juan11Manel Juan12Manel Juan13Immunology Unit, Department of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallès, SpainLaboratory of Cellular Immunology, Institute of Biotechnology and Biomedicine (IBB), Cerdanyola del Vallès, SpainImmunology Department, Hospital Cl´ınic de Barcelona, Centre de Diagnòstic Biomèdic (CDB), Barcelona, SpainImmunology Department, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) –Fundació Clínic per a la Recerca Biomèdica (FCRB) Universitat de Barcelona (UB), Barcelona, SpainImmunology Department, Hospital Cl´ınic de Barcelona, Centre de Diagnòstic Biomèdic (CDB), Barcelona, SpainImmunology Department, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) –Fundació Clínic per a la Recerca Biomèdica (FCRB) Universitat de Barcelona (UB), Barcelona, SpainImmunology Department, Hospital Cl´ınic de Barcelona, Centre de Diagnòstic Biomèdic (CDB), Barcelona, SpainImmunology Department, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) –Fundació Clínic per a la Recerca Biomèdica (FCRB) Universitat de Barcelona (UB), Barcelona, SpainImmunology Department, Hospital Sant Joan de Déu, Barcelona, SpainImmunology Unit, Department of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallès, SpainLaboratory of Cellular Immunology, Institute of Biotechnology and Biomedicine (IBB), Cerdanyola del Vallès, SpainImmunology Department, Hospital Cl´ınic de Barcelona, Centre de Diagnòstic Biomèdic (CDB), Barcelona, SpainImmunology Department, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) –Fundació Clínic per a la Recerca Biomèdica (FCRB) Universitat de Barcelona (UB), Barcelona, SpainImmunology Department, Hospital Sant Joan de Déu, Barcelona, Spainhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.1078003/fullT cellschimeric antigen receptor (CAR)ligandsreceptorantigenCAAR
spellingShingle Alejandro Ramírez-Chacón
Alejandro Ramírez-Chacón
Sergi Betriu-Méndez
Sergi Betriu-Méndez
Ariadna Bartoló-Ibars
Ariadna Bartoló-Ibars
Azucena González
Azucena González
Azucena González
Mercè Martí
Mercè Martí
Manel Juan
Manel Juan
Manel Juan
Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments
Frontiers in Immunology
T cells
chimeric antigen receptor (CAR)
ligands
receptor
antigen
CAAR
title Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments
title_full Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments
title_fullStr Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments
title_full_unstemmed Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments
title_short Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments
title_sort corrigendum ligand based car t cell different strategies to drive t cells in future new treatments
topic T cells
chimeric antigen receptor (CAR)
ligands
receptor
antigen
CAAR
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1078003/full
work_keys_str_mv AT alejandroramirezchacon corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments
AT alejandroramirezchacon corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments
AT sergibetriumendez corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments
AT sergibetriumendez corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments
AT ariadnabartoloibars corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments
AT ariadnabartoloibars corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments
AT azucenagonzalez corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments
AT azucenagonzalez corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments
AT azucenagonzalez corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments
AT mercemarti corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments
AT mercemarti corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments
AT maneljuan corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments
AT maneljuan corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments
AT maneljuan corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments